CliffBio
small molecule

NUCYNTA ER

TAPENTADOL HYDROCHLORIDE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyCollegium Pharmaceutical →See this company's full patent-cliff portfolio

Drug detail

Brand nameNUCYNTA ER
Active ingredientTAPENTADOL HYDROCHLORIDE
StrengthEQ 150MG BASE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2011
Marketing statusRX

Listed patents

PatentExpiresType
8536130*PEDMarch 2029—
11344512*PEDOctober 2028—
8536130September 2028use U-1276
11344512April 2028use U-3391

More from Collegium Pharmaceutical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

NUCYNTA ER patent cliff — loss of exclusivity March 2029 | CliffBio